Marina Basina, MD
Endocrinology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Community Hospital of the Monterey Peninsula · Mills-Peninsula Medical Center · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Basina’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A72355 · Current
Licensed to practise in California · since 2000 · expires 2028-04-30 · Moscow Medical Stomatological Institute.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Hospital of the Monterey Peninsula
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.48 (1.22 to 1.74) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.12 (1.69 to 4.56) · 1,095 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 19.24 (14.17 to 24.3) · 1,118 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 9.62 (6.42 to 12.82) · 1,086 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.39 to 2.16) · 1,873 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.2 (110.65 to 205.75) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 686 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 1,072 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,300 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.11 to 0.48) · 10,234 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.46) · 10,572 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (1.47 to 5.04) · 2,617 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.04 to 3.7) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.21 (0.75 to 3.66) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.06 to 1.17) · 8,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 156 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.732 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 152 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 625 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.3 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.2 · 749 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 1,074 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 850 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.7 to 5.8) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.4 to 17.4) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.9 to 18.6) · 711 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$132,515
Medicare paid this office $132,515 for 704 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 231 | $40,112 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 130 | $33,280 | $70 |
| Return visit (30+ min) | 235 | $27,515 | $84 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 115 | $13,969 | $115 |
| New patient visit (60+ min) | 22 | $3,427 | $156 |
See all 11 services
| Return visit (30+ min) | 231 | $40,112 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 130 | $33,280 | $70 |
| Return visit (30+ min) | 235 | $27,515 | $84 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 115 | $13,969 | $115 |
| New patient visit (60+ min) | 22 | $3,427 | $156 |
| New patient visit (45+ min) | 26 | $2,863 | $110 |
| Short return visit (20+ min) | 32 | $2,662 | $78 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $2,382 | $119 |
| New patient visit (45+ min) | 17 | $2,367 | $139 |
| Short return visit (20+ min) | 18 | $1,009 | $56 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 13 | $282 | $22 |
Who their Medicare patients are
704 Original Medicare patients in 2024. Average age 72 · Under 65 17% · 85 and older 9% · Women 54% · Also on Medicaid 35% · Health risk score 2.30. Sicker patients than 9 in 10 peers; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 42% · Coronary heart disease 38% · Depression 27% · Heart failure 26% · Atrial fibrillation 24% · Cancer 20% · COPD 16% · Stroke 11% · Dementia 10%.
The office billed $571,903, Medicare allowed $172,767 and paid $132,515; for 1,446 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 704 | 1,446 | 72 | 2.30 | $571,903 | $132,515 |
| 2023 | 636 | 1,382 | 71 | 2.55 | $533,909 | $115,281 |
| 2022 | 627 | 1,457 | 70 | 2.32 | $555,750 | $113,269 |
| 2021 | 622 | 1,442 | 70 | 2.14 | $588,114 | $113,158 |
| 2020 | 674 | 1,507 | 69 | 2.17 | $507,518 | $104,719 |
| 2019 | 619 | 1,333 | 69 | 2.20 | $200,014 | $81,894 |
| 2018 | 653 | 1,357 | 70 | 2.27 | $194,578 | $77,740 |
| 2017 | 599 | 1,198 | 70 | 2.21 | $187,163 | $65,346 |
| 2016 | 624 | 1,238 | 70 | 1.94 | $198,352 | $64,569 |
| 2015 | 618 | 1,244 | 69 | 2.06 | $222,440 | $69,477 |
| 2014 | 591 | 1,165 | 69 | 1.71 | $210,865 | $63,816 |
| 2013 | 583 | 1,300 | 68 | 1.93 | $245,561 | $74,789 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 394 | $50,807 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 130 | $33,240 | $73 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 120 | $15,963 | $120 |
| New patient visit (60+ min) | 38 | $5,678 | $149 |
| Long return visit (40+ min) | 13 | $1,862 | $133 |
| Short return visit (20+ min) | 30 | $1,769 | $59 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $1,693 | $85 |
2022: 9 services
| Return visit (30+ min) | 393 | $52,912 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 119 | $33,294 | $65 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 96 | $8,733 | $88 |
| New patient visit (60+ min) | 46 | $7,060 | $153 |
| Telephone medical discussion with physician, 21-30 minutes | 32 | $3,506 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $2,886 | $93 |
| Long return visit (40+ min) | 12 | $1,342 | $103 |
| Short return visit (20+ min) | 21 | $916 | $44 |
| Return visit (30+ min) | 13 | $891 | $52 |
2021: 11 services
| Return visit (30+ min) | 392 | $53,535 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 106 | $32,332 | $65 |
| New patient visit (60+ min) | 43 | $6,900 | $160 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 66 | $6,726 | $91 |
| Telephone medical discussion with physician, 21-30 minutes | 44 | $3,614 | $70 |
| Long return visit (40+ min) | 17 | $2,227 | $124 |
| Short return visit (20+ min) | 41 | $2,202 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,814 | $95 |
| New patient visit (45+ min) | 11 | $1,053 | $96 |
| Return visit (30+ min) | 13 | $917 | $61 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 13 | $436 | $31 |
2020: 9 services
| Return visit (30+ min) | 351 | $36,127 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 113 | $31,783 | $67 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 107 | $11,049 | $93 |
| Telephone medical discussion with physician, 21-30 minutes | 104 | $8,442 | $72 |
| New patient visit (45+ min) | 64 | $7,236 | $113 |
| Return visit (30+ min) | 44 | $3,388 | $66 |
| Short return visit (20+ min) | 64 | $2,118 | $32 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 11 | $310 | $28 |
| Telehealth originating site facility fee | 11 | $234 | $21 |
2019: 7 services
| Return visit (30+ min) | 302 | $29,963 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $25,140 | $66 |
| Short return visit (20+ min) | 256 | $12,665 | $39 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 58 | $6,123 | $90 |
| New patient visit (45+ min) | 38 | $4,315 | $114 |
| New patient visit (30+ min) | 19 | $1,234 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $959 | $33 |
2018: 7 services
| Return visit (30+ min) | 232 | $23,778 | $66 |
| Short return visit (20+ min) | 301 | $15,699 | $41 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $15,022 | $65 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 80 | $7,814 | $90 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 68 | $5,665 | $35 |
| New patient visit (45+ min) | 44 | $4,939 | $112 |
| New patient visit (30+ min) | 50 | $3,127 | $63 |
2017: 7 services
| Return visit (30+ min) | 202 | $19,449 | $65 |
| Short return visit (20+ min) | 314 | $17,864 | $41 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 66 | $6,637 | $34 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 64 | $6,011 | $88 |
| New patient visit (45+ min) | 52 | $5,776 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $5,377 | $65 |
| New patient visit (30+ min) | 41 | $2,580 | $63 |
2016: 9 services
| Short return visit (20+ min) | 346 | $22,193 | $41 |
| Return visit (30+ min) | 174 | $15,560 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 74 | $6,244 | $34 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 60 | $5,822 | $88 |
| New patient visit (30+ min) | 89 | $5,492 | $62 |
| New patient visit (45+ min) | 49 | $5,266 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,672 | $64 |
| Fine needle aspiration using imaging guidance | 14 | $877 | $58 |
| Ultrasonic guidance for needle placement | 13 | $390 | $30 |
2015: 9 services
| Return visit (30+ min) | 243 | $23,830 | $64 |
| Short return visit (20+ min) | 291 | $17,882 | $42 |
| New patient visit (45+ min) | 56 | $6,448 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $5,432 | $65 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 52 | $4,934 | $90 |
| New patient visit (30+ min) | 73 | $4,685 | $64 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 53 | $4,595 | $35 |
| Fine needle aspiration using imaging guidance | 12 | $718 | $55 |
| Ultrasonic guidance for needle placement | 12 | $356 | $30 |
2014: 9 services
| Return visit (30+ min) | 245 | $22,702 | $62 |
| Short return visit (20+ min) | 288 | $17,508 | $40 |
| New patient visit (45+ min) | 51 | $5,357 | $105 |
| New patient visit (30+ min) | 68 | $4,252 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $3,459 | $64 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 37 | $3,364 | $89 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 45 | $3,297 | $35 |
| New patient visit (60+ min) | 12 | $1,795 | $150 |
| Fine needle aspiration using imaging guidance | 16 | $993 | $58 |
2013: 7 services
| Return visit (30+ min) | 286 | $29,741 | $63 |
| Short return visit (20+ min) | 263 | $15,632 | $40 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $9,972 | $62 |
| New patient visit (30+ min) | 97 | $6,006 | $62 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 54 | $5,420 | $87 |
| New patient visit (45+ min) | 49 | $5,115 | $104 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,175 | $34 |
Medicaid work
$65,781 in 2024
Medicaid paid $65,781 for 1,016 billed services this clinician did in 2024, up to 46 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 407 | $29,928 |
| Long return visit (40+ min) | 131 | $17,506 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 452 | $16,613 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 26 | $1,734 |
| 2024 | 1,016 | 4 | 46 | $65,781 |
| 2023 | 1,095 | 4 | 77 | $41,198 |
| 2022 | 952 | 4 | 69 | $33,543 |
| 2021 | 535 | 3 | 43 | $18,452 |
| 2020 | 520 | 5 | 44 | $17,078 |
| 2019 | 359 | 2 | 34 | $10,784 |
| 2018 | 375 | 2 | 25 | $11,551 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 614 | $24,731 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 455 | $15,529 |
| Long return visit (40+ min) | 14 | $892 |
| Telehealth originating site facility fee | 12 | $46 |
2022
| Return visit (30+ min) | 596 | $23,277 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 325 | $8,995 |
| IP/OBS CONSLTJ NEW/EST PT LOW MDM 45 MINUTES | 16 | $1,179 |
| Telehealth originating site facility fee | 15 | $92 |
2021
| Return visit (30+ min) | 409 | $15,531 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 81 | $2,367 |
| Telehealth originating site facility fee | 45 | $555 |
2020
| Return visit (30+ min) | 379 | $12,837 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 51 | $2,587 |
| IP/OBS CONSLTJ NEW/EST PT LOW MDM 45 MINUTES | 13 | $896 |
| Telehealth originating site facility fee | 63 | $532 |
| 1ST HOSP IP/OBS SF/LOW 40 | 14 | $226 |
2019
| Return visit (30+ min) | 271 | $8,620 |
| Short return visit (20+ min) | 88 | $2,164 |
2018
| Return visit (30+ min) | 225 | $7,730 |
| Short return visit (20+ min) | 150 | $3,821 |
Drugs they prescribed that Part D paid
$4,197,501
Pharmacies billed $4,197,501 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 7,522) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
2,537 generic and 4,108 brand-name prescriptions · $4,197,501 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 471 | $681,805 | $1,448 |
| Ozempic | 397 | $568,589 | $1,432 |
| Trulicity | 329 | $507,924 | $1,544 |
| Jardiance | 355 | $489,198 | $1,378 |
| Rybelsus | 86 | $180,292 | $2,096 |
See all 87 drugs
| Mounjaro | 471 | $681,805 | $1,448 |
| Ozempic | 397 | $568,589 | $1,432 |
| Trulicity | 329 | $507,924 | $1,544 |
| Jardiance | 355 | $489,198 | $1,378 |
| Rybelsus | 86 | $180,292 | $2,096 |
| Creon | 40 | $151,676 | $3,792 |
| Januvia | 101 | $125,102 | $1,239 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | 58 | $100,421 | $1,731 |
| Tresiba Flextouch U-200 | 123 | $100,267 | $815 |
| Tymlos | 31 | $89,009 | $2,871 |
| Fiasp Flextouch | 81 | $88,543 | $1,093 |
| Teriparatide | 18 | $70,397 | $3,911 |
| Tresiba Flextouch U-100 | 115 | $61,793 | $537 |
| Toujeo Solostar | 59 | $60,082 | $1,018 |
| Farxiga | 45 | $53,776 | $1,195 |
| Tradjenta | 45 | $53,179 | $1,182 |
| Humalog Kwikpen U-100 | 159 | $47,690 | $300 |
| Fiasp | 24 | $45,489 | $1,895 |
| Nano 2nd Gen Pen Needle | 307 | $45,331 | $148 |
| Basaglar Kwikpen U-100 | 134 | $43,122 | $322 |
| Humalog Kwikpen U-200 | 25 | $37,737 | $1,509 |
| Gvoke Hypopen 2-Pack | 23 | $33,857 | $1,472 |
| Novolog Flexpen | 92 | $28,680 | $312 |
| Omnipod Dash Pods (Gen 4) | 15 | $27,145 | $1,810 |
| Invokana | 15 | $24,075 | $1,605 |
| Toujeo Max Solostar | 28 | $23,324 | $833 |
| Lantus Solostar | 200 | $20,840 | $104 |
| Insulin Aspart Flexpen | 93 | $18,619 | $200 |
| Humulin R U-500 Kwikpen | 22 | $17,068 | $776 |
| Insulin Lispro Kwikpen U-100 | 73 | $16,794 | $230 |
| Humalog | 55 | $16,694 | $304 |
| Novolog Mix 70-30 Flexpen | 61 | $15,029 | $246 |
| Victoza 3-Pak | 15 | $14,785 | $986 |
| Humalog Mix 75-25 Kwikpen | 32 | $14,196 | $444 |
| Ultra-Fine Nano Pen Needle | 139 | $13,152 | $95 |
| Novolog | 44 | $11,624 | $264 |
| Ultra-Fine Short Pen Needle | 74 | $9,368 | $127 |
| Baqsimi | 22 | $9,168 | $417 |
| Synthroid | 105 | $8,764 | $83 |
| Insulin Lispro Protamine Mix | 27 | $8,558 | $317 |
| Humalog Mix 50-50 Kwikpen | 13 | $8,158 | $628 |
| Comfort Ez Pen Needle | 53 | $7,573 | $143 |
| Omnipod 5 Dexg7g6 Intro(Gen 5) | 12 | $7,203 | $600 |
| Levothyroxine | 580 | $7,172 | $12 |
| Insulin Glargine-Yfgn | 76 | $6,711 | $88 |
| Praluent | 12 | $5,599 | $467 |
| Humulin N Kwikpen | 17 | $5,153 | $303 |
| Ultra-Fine Mini Pen Needle | 36 | $4,815 | $134 |
| Insulin Aspart | 22 | $4,333 | $197 |
| Metformin | 467 | $4,099 | $9 |
| Semglee (Yfgn) | 11 | $3,714 | $338 |
| Repaglinide | 119 | $3,507 | $29 |
| Novolin 70-30 | 20 | $2,785 | $139 |
| Droplet Pen Needle | 31 | $2,674 | $86 |
| Insulin Aspart Prot Mix 70-30 | 12 | $2,665 | $222 |
| Hydrocortisone | 55 | $2,580 | $47 |
| Levemir Flexpen | 15 | $2,257 | $150 |
| Metformin Hcl Er | 243 | $2,065 | $8 |
| Glipizide | 195 | $2,016 | $10 |
| Testosterone | 13 | $2,010 | $155 |
| Alcohol Prep Pads | 17 | $1,731 | $102 |
| Insulin Lispro | 22 | $1,666 | $76 |
| Glipizide Er | 68 | $1,587 | $23 |
| Cinacalcet | 13 | $1,534 | $118 |
| Rosuvastatin | 82 | $1,521 | $19 |
| Atorvastatin | 138 | $1,483 | $11 |
| Lantus | 11 | $1,293 | $118 |
| Insulin | 15 | $1,157 | $77 |
| Ultra-Fine Original Pen Needle | 13 | $1,003 | $77 |
| Acarbose | 16 | $1,002 | $63 |
| Pioglitazone | 40 | $784 | $20 |
| Alendronate | 71 | $655 | $9 |
| Pravastatin | 41 | $540 | $13 |
| Methimazole | 50 | $490 | $10 |
| Losartan | 52 | $454 | $9 |
| Prednisone | 26 | $436 | $17 |
| Fludrocortisone Acetate | 30 | $320 | $11 |
| Gabapentin | 26 | $309 | $12 |
| Lisinopril | 27 | $280 | $10 |
| Simvastatin | 25 | $249 | $10 |
| Glimepiride | 31 | $218 | $7 |
| Pregabalin | 11 | $142 | $13 |
| Amlodipine Besylate | 26 | $137 | $5 |
| Ezetimibe | 15 | $137 | $9 |
| Omeprazole | 16 | $88 | $6 |
| Easy Touch Alcohol Prep Pads | 12 | $52 | $4 |
| Ondansetron Odt | 12 | $27 | $2 |
Year by year
| 2024 | 7,522 | 716 | 0% (0) | 55% | $4,197,501 |
| 2023 | 6,785 | 664 | 0% (0) | 53% | $4,526,934 |
| 2022 | 6,756 | 690 | 0% (0) | 52% | $4,035,722 |
| 2021 | 6,753 | 655 | 0% (0) | 50% | $3,573,194 |
| 2020 | 6,318 | 616 | 0% (0) | 49% | $3,296,597 |
| 2019 | 6,177 | 582 | None | 48% | $3,783,169 |
| 2018 | 6,623 | 588 | 0% (0) | 48% | $2,509,221 |
| 2017 | 6,341 | 584 | None | 47% | $2,060,777 |
| 2016 | 6,040 | 556 | 0% (0) | 41% | $1,630,986 |
| 2015 | 5,299 | 499 | 0% (0) | 41% | $1,215,547 |
| 2014 | 4,893 | 466 | None | 42% | $970,242 |
| 2013 | 4,820 | 434 | 0% (19) | 40% | $739,452 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 91 drugs
| Trulicity | 481 | $787,299 | $1,637 |
| Ozempic | 307 | $534,867 | $1,742 |
| Jardiance | 286 | $446,195 | $1,560 |
| Mounjaro | 121 | $215,308 | $1,779 |
| Novolog Flexpen | 195 | $207,697 | $1,065 |
| Rybelsus | 86 | $182,007 | $2,116 |
| Creon | 37 | $166,607 | $4,503 |
| Januvia | 79 | $122,673 | $1,553 |
| Humalog Kwikpen U-100 | 101 | $110,477 | $1,094 |
| Novolog | 63 | $108,218 | $1,718 |
| Tresiba Flextouch U-200 | 94 | $103,176 | $1,098 |
| Novolog Mix 70-30 Flexpen | 83 | $100,479 | $1,211 |
| Forteo | 19 | $95,780 | $5,041 |
| Humalog | 65 | $92,859 | $1,429 |
| Tradjenta | 64 | $86,799 | $1,356 |
| Lantus Solostar | 164 | $83,969 | $512 |
| Farxiga | 44 | $61,097 | $1,389 |
| Tresiba Flextouch U-100 | 105 | $56,641 | $539 |
| Humalog Mix 75-25 Kwikpen | 33 | $56,263 | $1,705 |
| Toujeo Solostar | 54 | $55,461 | $1,027 |
| Omnipod 5 G6 Pods (Gen 5) | 22 | $48,318 | $2,196 |
| Basaglar Kwikpen U-100 | 109 | $44,374 | $407 |
| Gvoke Hypopen 2-Pack | 37 | $42,225 | $1,141 |
| Nano 2nd Gen Pen Needle | 250 | $34,396 | $138 |
| Teriparatide | 12 | $29,706 | $2,475 |
| Humalog Kwikpen U-200 | 24 | $29,603 | $1,233 |
| Humulin N Kwikpen | 27 | $28,217 | $1,045 |
| Invokana | 16 | $27,875 | $1,742 |
| Victoza 3-Pak | 18 | $26,721 | $1,484 |
| Toujeo Max Solostar | 19 | $23,238 | $1,223 |
| Omnipod Dash Pods (Gen 4) | 16 | $23,192 | $1,449 |
| Novolog Penfill | 14 | $21,022 | $1,502 |
| Humulin R U-500 Kwikpen | 16 | $17,512 | $1,094 |
| Lyumjev Kwikpen U-200 | 11 | $16,484 | $1,499 |
| Insulin Aspart | 33 | $16,061 | $487 |
| Levemir Flexpen | 22 | $14,004 | $637 |
| Insulin Aspart Flexpen | 38 | $12,864 | $339 |
| Levothyroxine | 541 | $11,291 | $21 |
| Repaglinide | 117 | $10,861 | $93 |
| Insulin Glargine-Yfgn | 64 | $10,105 | $158 |
| Ultra-Fine Nano Pen Needle | 88 | $9,955 | $113 |
| Insulin Lispro Kwikpen U-100 | 42 | $9,354 | $223 |
| Lantus | 13 | $9,310 | $716 |
| Ultra-Fine Short Pen Needle | 60 | $8,856 | $148 |
| Comfort Ez Pen Needle | 61 | $8,115 | $133 |
| Metformin | 472 | $7,825 | $17 |
| Novolin 70-30 | 24 | $7,547 | $314 |
| Levemir | 13 | $6,960 | $535 |
| Synthroid | 76 | $6,730 | $89 |
| Praluent | 12 | $6,376 | $531 |
| Ultra-Fine Mini Pen Needle | 36 | $5,482 | $152 |
| Glipizide | 233 | $5,028 | $22 |
| Admelog Solostar | 14 | $4,980 | $356 |
| Tirosint | 14 | $4,382 | $313 |
| Droplet Pen Needle | 44 | $4,225 | $96 |
| Semglee (Yfgn) | 12 | $4,097 | $341 |
| Hydrocortisone | 64 | $3,757 | $59 |
| Premarin | 12 | $3,530 | $294 |
| Metformin Hcl Er | 194 | $3,069 | $16 |
| Insulin Degludec Pen (U-200) | 13 | $2,924 | $225 |
| Insulin Lispro | 21 | $2,537 | $121 |
| Glipizide Er | 103 | $2,162 | $21 |
| Alcohol Prep Pads | 22 | $1,761 | $80 |
| Pravastatin | 54 | $1,678 | $31 |
| Atorvastatin | 112 | $1,669 | $15 |
| Insulin | 13 | $1,632 | $126 |
| Rosuvastatin | 47 | $1,453 | $31 |
| Pregabalin | 23 | $1,214 | $53 |
| Gabapentin | 36 | $1,102 | $31 |
| Nateglinide | 14 | $1,040 | $74 |
| Potassium Chloride | 11 | $1,017 | $92 |
| Alendronate | 74 | $980 | $13 |
| Sure Comfort | 12 | $906 | $75 |
| Ultra-Fine Micro Pen Needle | 11 | $789 | $72 |
| Glimepiride | 37 | $765 | $21 |
| Methimazole | 48 | $764 | $16 |
| Pioglitazone | 27 | $739 | $27 |
| Acarbose | 16 | $728 | $45 |
| Losartan | 41 | $693 | $17 |
| Ultra-Fine Original Pen Needle | 11 | $689 | $63 |
| Fludrocortisone Acetate | 27 | $677 | $25 |
| Prednisone | 26 | $526 | $20 |
| Simvastatin | 29 | $467 | $16 |
| Amlodipine Besylate | 29 | $356 | $12 |
| Ezetimibe | 12 | $336 | $28 |
| Calcitriol | 11 | $309 | $28 |
| Lisinopril | 30 | $251 | $8 |
| Omeprazole | 12 | $216 | $18 |
| Allopurinol | 12 | $149 | $12 |
| Single Use Swab | 12 | $53 | $4 |
| Medroxyprogesterone Acetate | 13 | $28 | $2 |
2022: 89 drugs
| Trulicity | 555 | $807,197 | $1,454 |
| Ozempic | 251 | $417,557 | $1,664 |
| Jardiance | 309 | $401,648 | $1,300 |
| Novolog Flexpen | 200 | $212,576 | $1,063 |
| Januvia | 100 | $138,048 | $1,380 |
| Novolog | 75 | $136,076 | $1,814 |
| Lantus Solostar | 258 | $123,143 | $477 |
| Novolog Mix 70-30 Flexpen | 88 | $116,605 | $1,325 |
| Rybelsus | 69 | $112,664 | $1,633 |
| Tresiba Flextouch U-200 | 105 | $104,163 | $992 |
| Creon | 31 | $91,502 | $2,952 |
| Humalog Kwikpen U-100 | 93 | $88,124 | $948 |
| Tradjenta | 63 | $85,841 | $1,363 |
| Humalog Mix 75-25 Kwikpen | 47 | $83,690 | $1,781 |
| Toujeo Solostar | 79 | $75,984 | $962 |
| Farxiga | 60 | $64,883 | $1,081 |
| Humalog | 59 | $61,776 | $1,047 |
| Forteo | 14 | $59,650 | $4,261 |
| Teriparatide | 23 | $59,084 | $2,569 |
| Humalog Kwikpen U-200 | 28 | $50,190 | $1,793 |
| Tresiba Flextouch U-100 | 71 | $42,341 | $596 |
| Mounjaro | 18 | $28,064 | $1,559 |
| Nano 2nd Gen Pen Needle | 223 | $28,060 | $126 |
| Basaglar Kwikpen U-100 | 63 | $26,542 | $421 |
| Invokana | 18 | $25,411 | $1,412 |
| Humulin N Kwikpen | 25 | $24,832 | $993 |
| Lantus | 49 | $22,531 | $460 |
| Omnipod Dash Pods (Gen 4) | 16 | $21,616 | $1,351 |
| Novolog Penfill | 12 | $18,714 | $1,559 |
| Victoza 3-Pak | 14 | $17,945 | $1,282 |
| Toujeo Max Solostar | 13 | $16,704 | $1,285 |
| Insulin Aspart | 32 | $15,975 | $499 |
| Humulin R U-500 Kwikpen | 14 | $15,685 | $1,120 |
| Gvoke Hypopen 2-Pack | 24 | $15,335 | $639 |
| Insulin Lispro Kwikpen U-100 | 62 | $14,868 | $240 |
| Levemir Flextouch | 20 | $14,368 | $718 |
| Lyumjev Kwikpen U-200 | 14 | $14,163 | $1,012 |
| Comfort Ez Pen Needle | 128 | $13,779 | $108 |
| Humalog Mix 75-25 | 11 | $13,670 | $1,243 |
| Levothyroxine | 473 | $10,627 | $22 |
| Novolin 70-30 | 19 | $10,418 | $548 |
| Insulin Aspart Prot Mix 70-30 | 13 | $9,135 | $703 |
| Repaglinide | 139 | $8,312 | $60 |
| Insulin Aspart Flexpen | 24 | $7,788 | $324 |
| Insulin Lispro Protamine Mix | 19 | $7,346 | $387 |
| Admelog Solostar | 23 | $7,264 | $316 |
| Ultra-Fine Short Pen Needle | 45 | $6,752 | $150 |
| Ultra-Fine Nano Pen Needle | 54 | $6,331 | $117 |
| Metformin | 483 | $6,330 | $13 |
| Synthroid | 74 | $6,157 | $83 |
| Novolin N Flexpen | 12 | $3,705 | $309 |
| Glipizide | 268 | $3,629 | $14 |
| Ultra-Fine Mini Pen Needle | 29 | $3,476 | $120 |
| Testosterone | 12 | $2,404 | $200 |
| Droplet Pen Needle | 21 | $2,297 | $109 |
| Glipizide Er | 124 | $2,125 | $17 |
| Hydrocortisone | 45 | $2,114 | $47 |
| Insulin | 19 | $2,093 | $110 |
| Metformin Hcl Er | 176 | $2,019 | $11 |
| Pen Needles | 14 | $1,845 | $132 |
| Comfort Ez Insulin | 11 | $1,805 | $164 |
| Insulin | 26 | $1,591 | $61 |
| Atorvastatin | 123 | $1,509 | $12 |
| Rosuvastatin | 34 | $1,485 | $44 |
| Insulin Lispro | 13 | $1,433 | $110 |
| Glimepiride | 48 | $1,324 | $28 |
| Gabapentin | 51 | $1,266 | $25 |
| Alendronate | 90 | $1,077 | $12 |
| Pravastatin | 56 | $916 | $16 |
| Ezetimibe | 12 | $836 | $70 |
| Acarbose | 17 | $817 | $48 |
| Pioglitazone | 45 | $800 | $18 |
| Methimazole | 62 | $687 | $11 |
| Prednisone | 42 | $687 | $16 |
| Potassium Chloride | 15 | $602 | $40 |
| Insulin | 12 | $595 | $50 |
| Testosterone Cypionate | 14 | $512 | $37 |
| Alcohol Prep Pads | 12 | $482 | $40 |
| Nateglinide | 12 | $473 | $39 |
| Fludrocortisone Acetate | 16 | $469 | $29 |
| Losartan | 33 | $359 | $11 |
| Simvastatin | 31 | $324 | $10 |
| Pregabalin | 12 | $232 | $19 |
| Omeprazole | 11 | $221 | $20 |
| Allopurinol | 11 | $210 | $19 |
| Lisinopril | 24 | $162 | $7 |
| Amlodipine Besylate | 29 | $109 | $4 |
| Hydrochlorothiazide | 11 | $52 | $5 |
| Trazodone | 11 | $47 | $4 |
2021: 83 drugs
| Trulicity | 524 | $752,515 | $1,436 |
| Jardiance | 278 | $355,189 | $1,278 |
| Ozempic | 152 | $215,663 | $1,419 |
| Novolog Flexpen | 211 | $185,436 | $879 |
| Creon | 28 | $150,010 | $5,358 |
| Januvia | 117 | $147,298 | $1,259 |
| Rybelsus | 83 | $121,245 | $1,461 |
| Tresiba Flextouch U-200 | 133 | $120,874 | $909 |
| Novolog Mix 70-30 Flexpen | 91 | $105,250 | $1,157 |
| Humalog Kwikpen U-100 | 109 | $100,811 | $925 |
| Lantus Solostar | 214 | $99,342 | $464 |
| Toujeo Solostar | 99 | $88,997 | $899 |
| Tradjenta | 86 | $86,563 | $1,007 |
| Novolog | 64 | $78,511 | $1,227 |
| Humalog Mix 75-25 Kwikpen | 56 | $69,713 | $1,245 |
| Humalog Kwikpen U-200 | 32 | $63,149 | $1,973 |
| Forteo | 14 | $51,043 | $3,646 |
| Farxiga | 57 | $47,933 | $841 |
| Humalog | 45 | $46,924 | $1,043 |
| Victoza 3-Pak | 27 | $42,192 | $1,563 |
| Tymlos | 12 | $33,783 | $2,815 |
| Basaglar Kwikpen U-100 | 79 | $31,940 | $404 |
| Tresiba Flextouch U-100 | 58 | $31,349 | $540 |
| Insulin Lispro Kwikpen U-100 | 74 | $29,373 | $397 |
| Nano 2nd Gen Pen Needle | 242 | $28,012 | $116 |
| Humulin N Kwikpen | 25 | $25,220 | $1,009 |
| Lantus | 49 | $22,199 | $453 |
| Omnipod Dash | 14 | $21,087 | $1,506 |
| Invokana | 15 | $21,026 | $1,402 |
| Humulin R U-500 | 12 | $17,923 | $1,494 |
| Humulin 70/30 Kwikpen | 13 | $16,576 | $1,275 |
| Humulin R U-500 Kwikpen | 12 | $15,067 | $1,256 |
| Comfort Ez Pen Needle | 138 | $15,045 | $109 |
| Novolin 70-30 | 23 | $12,815 | $557 |
| Insulin Aspart | 27 | $12,042 | $446 |
| Levothyroxine | 466 | $12,019 | $26 |
| Insulin Lispro Protamine Mix | 20 | $11,362 | $568 |
| Humalog Mix 75-25 | 12 | $11,280 | $940 |
| Repaglinide | 114 | $9,702 | $85 |
| Insulin Aspart Flexpen | 24 | $9,233 | $385 |
| Ultra-Fine Nano Pen Needle | 76 | $7,892 | $104 |
| Insulin Lispro | 13 | $7,383 | $568 |
| Ultra-Fine Mini Pen Needle | 54 | $6,593 | $122 |
| Ultra-Fine Short Pen Needle | 46 | $6,162 | $134 |
| Synthroid | 72 | $5,986 | $83 |
| Gvoke Hypopen 2-Pack | 11 | $5,905 | $537 |
| Levemir Flextouch | 13 | $5,805 | $447 |
| Metformin | 520 | $5,458 | $10 |
| Admelog Solostar | 12 | $4,845 | $404 |
| Glipizide | 286 | $4,092 | $14 |
| Glipizide Er | 132 | $2,461 | $19 |
| Pen Needles | 17 | $2,293 | $135 |
| Comfort Ez Insulin | 12 | $1,974 | $165 |
| Hydrocortisone | 23 | $1,939 | $84 |
| Metformin Hcl Er | 179 | $1,907 | $11 |
| Atorvastatin | 115 | $1,680 | $15 |
| Insulin | 24 | $1,483 | $62 |
| Acarbose | 19 | $1,303 | $69 |
| Insulin | 26 | $1,228 | $47 |
| Glimepiride | 67 | $1,163 | $17 |
| Pioglitazone | 48 | $1,120 | $23 |
| Rosuvastatin | 30 | $872 | $29 |
| Pregabalin | 13 | $847 | $65 |
| Methimazole | 82 | $798 | $10 |
| Pravastatin | 52 | $744 | $14 |
| Prednisone | 50 | $711 | $14 |
| Alendronate | 81 | $703 | $9 |
| Gabapentin | 49 | $577 | $12 |
| Losartan | 43 | $562 | $13 |
| Alcohol Prep Pads | 12 | $557 | $46 |
| Fludrocortisone Acetate | 20 | $464 | $23 |
| Potassium Chloride | 17 | $426 | $25 |
| Fenofibrate | 12 | $424 | $35 |
| Nateglinide | 14 | $411 | $29 |
| Simvastatin | 57 | $309 | $5 |
| Atenolol | 13 | $259 | $20 |
| Omeprazole | 13 | $237 | $18 |
| Lisinopril | 18 | $219 | $12 |
| Hydrochlorothiazide | 12 | $189 | $16 |
| Glyburide | 11 | $183 | $17 |
| Trazodone | 26 | $178 | $7 |
| Metoprolol | 12 | $133 | $11 |
| Amlodipine Besylate | 22 | $112 | $5 |
2020: 74 drugs
| Trulicity | 450 | $505,080 | $1,122 |
| Jardiance | 242 | $278,900 | $1,152 |
| Januvia | 153 | $178,399 | $1,166 |
| Novolog Mix 70-30 Flexpen | 136 | $156,213 | $1,149 |
| Novolog Flexpen | 182 | $154,452 | $849 |
| Ozempic | 120 | $153,409 | $1,278 |
| Tresiba Flextouch U-200 | 118 | $101,898 | $864 |
| Humalog Kwikpen U-100 | 97 | $94,953 | $979 |
| Tradjenta | 107 | $93,619 | $875 |
| Toujeo Solostar | 117 | $91,214 | $780 |
| Novolog | 70 | $79,591 | $1,137 |
| Forteo | 21 | $78,713 | $3,748 |
| Lantus Solostar | 169 | $74,504 | $441 |
| Humalog Mix 75-25 Kwikpen | 72 | $66,487 | $923 |
| Creon | 19 | $57,034 | $3,002 |
| Humalog Kwikpen U-200 | 26 | $49,422 | $1,901 |
| Victoza 3-Pak | 29 | $47,613 | $1,642 |
| Humalog | 54 | $37,812 | $700 |
| Basaglar Kwikpen U-100 | 82 | $28,974 | $353 |
| Tresiba Flextouch U-100 | 49 | $27,074 | $553 |
| Tymlos | 13 | $26,682 | $2,052 |
| Insulin Lispro Kwikpen U-100 | 55 | $23,564 | $428 |
| Humulin N Kwikpen | 36 | $22,848 | $635 |
| Farxiga | 28 | $22,553 | $805 |
| Ultra-Fine Nano Pen Needle | 227 | $22,297 | $98 |
| Rybelsus | 11 | $19,179 | $1,744 |
| Invokana | 20 | $14,992 | $750 |
| Humulin 70/30 Kwikpen | 13 | $14,685 | $1,130 |
| Repaglinide | 110 | $14,618 | $133 |
| Comfort Ez Pen Needle | 119 | $13,779 | $116 |
| Levothyroxine | 471 | $13,017 | $28 |
| Cinacalcet | 21 | $11,720 | $558 |
| Victoza 2-Pak | 15 | $11,679 | $779 |
| Lantus | 20 | $7,517 | $376 |
| Novolin 70-30 | 15 | $7,413 | $494 |
| Levemir Flextouch | 13 | $7,180 | $552 |
| Nano 2nd Gen Pen Needle | 65 | $6,646 | $102 |
| Insulin Aspart Flexpen | 16 | $6,409 | $401 |
| Ultra-Fine Mini Pen Needle | 66 | $6,148 | $93 |
| Ultra-Fine Short Pen Needle | 50 | $5,882 | $118 |
| Glucagon Emergency Kit | 12 | $5,524 | $460 |
| Synthroid | 53 | $4,183 | $79 |
| Metformin | 440 | $4,032 | $9 |
| Glipizide | 260 | $3,604 | $14 |
| Glipizide Er | 165 | $2,899 | $18 |
| Insulin Aspart | 15 | $2,702 | $180 |
| Rosuvastatin | 40 | $2,218 | $55 |
| Metformin Hcl Er | 185 | $2,200 | $12 |
| Insulin | 35 | $1,818 | $52 |
| Pen Needles | 14 | $1,764 | $126 |
| Pioglitazone | 53 | $1,433 | $27 |
| Atorvastatin | 94 | $1,410 | $15 |
| Glimepiride | 67 | $1,374 | $21 |
| Pravastatin | 59 | $1,044 | $18 |
| Hydrocortisone | 28 | $1,034 | $37 |
| Alcohol Prep Pads | 19 | $956 | $50 |
| Gabapentin | 89 | $799 | $9 |
| Losartan | 48 | $790 | $16 |
| Methimazole | 77 | $645 | $8 |
| Testosterone Cypionate | 14 | $622 | $44 |
| Alendronate | 76 | $598 | $8 |
| Fludrocortisone Acetate | 16 | $520 | $32 |
| Prednisone | 33 | $508 | $15 |
| Insulin | 12 | $364 | $30 |
| Levoxyl | 11 | $347 | $32 |
| Potassium Chloride | 14 | $299 | $21 |
| Easy Touch Pen Needle | 11 | $292 | $27 |
| Fenofibrate | 13 | $283 | $22 |
| Simvastatin | 46 | $259 | $6 |
| Atenolol | 15 | $219 | $15 |
| Trazodone | 32 | $160 | $5 |
| Omeprazole | 18 | $124 | $7 |
| Amlodipine Besylate | 36 | $94 | $3 |
| Lisinopril | 11 | $69 | $6 |
2019: 74 drugs
| Trulicity | 340 | $334,455 | $984 |
| Forteo | 59 | $199,188 | $3,376 |
| Jardiance | 203 | $181,578 | $894 |
| Novolog Mix 70-30 Flexpen | 132 | $150,296 | $1,139 |
| Januvia | 150 | $149,583 | $997 |
| Novolog Flexpen | 154 | $123,114 | $799 |
| Tresiba Flextouch U-200 | 131 | $114,341 | $873 |
| Toujeo Solostar | 160 | $105,541 | $660 |
| Humalog Kwikpen U-100 | 111 | $104,491 | $941 |
| Novolog | 89 | $94,057 | $1,057 |
| Tradjenta | 105 | $80,830 | $770 |
| Victoza 3-Pak | 71 | $77,461 | $1,091 |
| Humalog Mix 75-25 Kwikpen | 63 | $74,681 | $1,185 |
| Humalog Kwikpen U-200 | 44 | $71,572 | $1,627 |
| Ozempic | 66 | $68,719 | $1,041 |
| Lantus Solostar | 132 | $63,335 | $480 |
| Humalog | 59 | $45,488 | $771 |
| Creon | 13 | $32,618 | $2,509 |
| Victoza 2-Pak | 37 | $26,415 | $714 |
| Ultra-Fine Nano Pen Needle | 291 | $24,149 | $83 |
| Humulin 70/30 Kwikpen | 23 | $22,667 | $986 |
| Invokana | 32 | $21,918 | $685 |
| Tresiba Flextouch U-100 | 46 | $20,807 | $452 |
| Basaglar Kwikpen U-100 | 54 | $20,168 | $373 |
| Humulin N Kwikpen | 30 | $19,390 | $646 |
| Cinacalcet | 17 | $16,516 | $972 |
| Farxiga | 20 | $12,972 | $649 |
| Levothyroxine | 512 | $12,863 | $25 |
| Comfort Ez Pen Needle | 106 | $11,775 | $111 |
| Levemir Flextouch | 30 | $11,740 | $391 |
| Lantus | 20 | $8,634 | $432 |
| Repaglinide | 86 | $7,988 | $93 |
| Onglyza | 15 | $7,361 | $491 |
| Novolin 70-30 | 14 | $5,601 | $400 |
| Ultra-Fine Short Pen Needle | 51 | $4,992 | $98 |
| Ultra-Fine Mini Pen Needle | 58 | $4,725 | $81 |
| Metformin | 446 | $4,617 | $10 |
| Glipizide | 341 | $4,369 | $13 |
| Synthroid | 46 | $4,132 | $90 |
| Glucagon Emergency Kit | 11 | $4,021 | $366 |
| Rosuvastatin | 23 | $2,927 | $127 |
| Glipizide Er | 155 | $2,697 | $17 |
| Alcohol Prep Pads | 23 | $2,664 | $116 |
| Atorvastatin | 112 | $2,430 | $22 |
| Metformin Hcl Er | 177 | $1,699 | $10 |
| Pioglitazone | 54 | $1,571 | $29 |
| Glimepiride | 64 | $1,516 | $24 |
| Pravastatin | 47 | $1,213 | $26 |
| Insulin | 31 | $1,177 | $38 |
| Hydrocortisone | 43 | $1,112 | $26 |
| Testosterone Cypionate | 14 | $875 | $62 |
| Calcitriol | 12 | $794 | $66 |
| Gabapentin | 82 | $756 | $9 |
| Alendronate | 72 | $678 | $9 |
| Losartan | 44 | $657 | $15 |
| Insulin | 18 | $596 | $33 |
| Methimazole | 76 | $567 | $7 |
| Fludrocortisone Acetate | 21 | $507 | $24 |
| Levoxyl | 12 | $468 | $39 |
| Amlodipine Besylate | 43 | $445 | $10 |
| Insulin Syringe U-500 | 13 | $410 | $32 |
| Simvastatin | 48 | $371 | $8 |
| Prednisone | 36 | $360 | $10 |
| Easy Touch Pen Needle | 12 | $313 | $26 |
| Glyburide | 12 | $303 | $25 |
| Lisinopril | 24 | $287 | $12 |
| Diclofenac | 11 | $278 | $25 |
| Glipizide Xl | 15 | $230 | $15 |
| Hydrochlorothiazide | 14 | $225 | $16 |
| Atenolol | 18 | $183 | $10 |
| Omeprazole | 18 | $139 | $8 |
| Trazodone | 22 | $122 | $6 |
| Single Use Swab | 16 | $76 | $5 |
| Topiramate | 11 | $46 | $4 |
2018: 86 drugs
| Trulicity | 222 | $223,494 | $1,007 |
| Forteo | 61 | $205,692 | $3,372 |
| Januvia | 182 | $165,880 | $911 |
| Natpara | 13 | $124,640 | $9,588 |
| Novolog Mix 70-30 Flexpen | 135 | $123,014 | $911 |
| Toujeo Solostar | 201 | $109,487 | $545 |
| Jardiance | 121 | $106,030 | $876 |
| Victoza 3-Pak | 100 | $103,936 | $1,039 |
| Humalog Kwikpen U-100 | 135 | $103,749 | $769 |
| Tresiba Flextouch U-200 | 136 | $100,547 | $739 |
| Humalog Mix 75-25 Kwikpen | 103 | $99,607 | $967 |
| Novolog Flexpen | 146 | $98,743 | $676 |
| Tradjenta | 133 | $98,645 | $742 |
| Humalog Kwikpen U-200 | 60 | $81,937 | $1,366 |
| Novolog | 93 | $77,579 | $834 |
| Lantus Solostar | 164 | $68,791 | $419 |
| Humalog | 102 | $60,009 | $588 |
| Sensipar | 39 | $42,250 | $1,083 |
| Invokana | 51 | $40,068 | $786 |
| Creon | 22 | $36,123 | $1,642 |
| Victoza 2-Pak | 45 | $29,365 | $653 |
| Humalog Mix 50-50 | 12 | $24,123 | $2,010 |
| Ultra-Fine Nano Pen Needle | 284 | $22,696 | $80 |
| Humulin 70/30 Kwikpen | 19 | $20,526 | $1,080 |
| Humulin N Kwikpen | 33 | $19,459 | $590 |
| Tresiba Flextouch U-100 | 46 | $19,187 | $417 |
| Humalog Mix 75-25 | 26 | $18,428 | $709 |
| Ozempic | 16 | $18,045 | $1,128 |
| Lantus | 57 | $16,623 | $292 |
| Levemir Flextouch | 32 | $12,997 | $406 |
| Janumet | 15 | $12,934 | $862 |
| Levothyroxine | 508 | $12,897 | $25 |
| Farxiga | 12 | $11,914 | $993 |
| Basaglar Kwikpen U-100 | 33 | $10,635 | $322 |
| Onglyza | 18 | $10,087 | $560 |
| Glucagon Emergency Kit | 13 | $6,019 | $463 |
| Repaglinide | 77 | $5,758 | $75 |
| Metformin | 472 | $4,921 | $10 |
| Humulin N | 15 | $4,749 | $317 |
| Ultra-Fine Mini Pen Needle | 72 | $4,663 | $65 |
| Ultra-Fine Short Pen Needle | 61 | $4,312 | $71 |
| Synthroid | 54 | $4,164 | $77 |
| Glipizide | 423 | $4,084 | $10 |
| Novolin 70-30 | 12 | $3,289 | $274 |
| Comfort Ez Pen Needle | 33 | $3,277 | $99 |
| Atorvastatin | 113 | $2,462 | $22 |
| Omega-3 Acid Ethyl Esters | 21 | $2,234 | $106 |
| Rosuvastatin | 13 | $2,205 | $170 |
| Alcohol Prep Pads | 13 | $2,146 | $165 |
| Glimepiride | 88 | $1,689 | $19 |
| Metformin Hcl Er | 157 | $1,602 | $10 |
| Pioglitazone | 81 | $1,601 | $20 |
| Hydrocortisone | 58 | $1,593 | $27 |
| Insulin | 56 | $1,571 | $28 |
| Pen Needles | 18 | $1,432 | $80 |
| Glipizide Er | 99 | $1,417 | $14 |
| Ibandronate | 12 | $1,340 | $112 |
| Methimazole | 105 | $975 | $9 |
| Pravastatin | 30 | $884 | $29 |
| Novofine Autocover | 11 | $780 | $71 |
| Alendronate | 112 | $762 | $7 |
| Testosterone Cypionate | 19 | $665 | $35 |
| Trueplus Pen Needle | 23 | $642 | $28 |
| Glipizide Xl | 42 | $582 | $14 |
| Insulin | 30 | $567 | $19 |
| Glyburide | 23 | $559 | $24 |
| Prednisone | 37 | $557 | $15 |
| Simvastatin | 41 | $499 | $12 |
| Fludrocortisone Acetate | 24 | $493 | $21 |
| Unifine Pentips | 20 | $492 | $25 |
| Gabapentin | 74 | $483 | $7 |
| Propranolol | 20 | $446 | $22 |
| Losartan | 38 | $427 | $11 |
| Sure Comfort | 14 | $404 | $29 |
| Easy Touch Pen Needle | 15 | $386 | $26 |
| Sure Comfort | 13 | $360 | $28 |
| Lisinopril | 38 | $337 | $9 |
| Potassium Chloride | 12 | $300 | $25 |
| Amlodipine Besylate | 35 | $266 | $8 |
| Trazodone | 40 | $201 | $5 |
| Levoxyl | 11 | $168 | $15 |
| Promethazine | 12 | $124 | $10 |
| Lovastatin | 11 | $114 | $10 |
| Hydrochlorothiazide | 12 | $65 | $5 |
| Single Use Swab | 13 | $62 | $5 |
| Topiramate | 18 | $54 | $3 |
2017: 86 drugs
| Januvia | 221 | $165,142 | $747 |
| Humalog Mix 75-25 Kwikpen | 174 | $154,538 | $888 |
| Forteo | 50 | $152,307 | $3,046 |
| Novolog Mix 70-30 Flexpen | 110 | $118,473 | $1,077 |
| Tradjenta | 182 | $109,449 | $601 |
| Toujeo Solostar | 211 | $94,473 | $448 |
| Humalog Kwikpen U-200 | 97 | $93,798 | $967 |
| Victoza 3-Pak | 80 | $80,045 | $1,001 |
| Tresiba Flextouch U-200 | 104 | $77,164 | $742 |
| Trulicity | 86 | $75,955 | $883 |
| Lantus Solostar | 171 | $65,864 | $385 |
| Humalog Kwikpen U-100 | 90 | $65,291 | $725 |
| Novolog | 92 | $63,425 | $689 |
| Jardiance | 70 | $59,395 | $849 |
| Novolog Flexpen | 86 | $54,821 | $637 |
| Invokana | 66 | $45,663 | $692 |
| Humulin R U-500 | 21 | $36,325 | $1,730 |
| Creon | 17 | $35,829 | $2,108 |
| Victoza 2-Pak | 52 | $34,319 | $660 |
| Humalog | 65 | $30,496 | $469 |
| Lantus | 64 | $25,521 | $399 |
| Janumet | 26 | $18,859 | $725 |
| Sensipar | 21 | $16,837 | $802 |
| Humulin R U-500 Kwikpen | 13 | $15,603 | $1,200 |
| Ultra-Fine Nano Pen Needle | 228 | $15,435 | $68 |
| Tresiba Flextouch U-100 | 39 | $15,388 | $395 |
| Humulin 70/30 Kwikpen | 14 | $13,897 | $993 |
| Levemir Flextouch | 33 | $13,576 | $411 |
| Levothyroxine | 487 | $12,692 | $26 |
| Humalog Mix 75-25 | 17 | $11,051 | $650 |
| Glucagon Emergency Kit | 22 | $10,205 | $464 |
| Humulin N Kwikpen | 16 | $7,529 | $471 |
| Humulin N | 20 | $7,154 | $358 |
| Repaglinide | 61 | $7,097 | $116 |
| Humulin 70-30 | 16 | $6,240 | $390 |
| Tanzeum | 11 | $5,728 | $521 |
| Onglyza | 11 | $5,691 | $517 |
| Nexium | 11 | $5,630 | $512 |
| Premarin | 12 | $5,447 | $454 |
| Ultra-Fine Mini Pen Needle | 82 | $4,387 | $54 |
| Ultra-Fine Short Pen Needle | 76 | $4,301 | $57 |
| Metformin | 505 | $4,170 | $8 |
| Novolin N | 30 | $4,108 | $137 |
| Glipizide | 444 | $4,000 | $9 |
| Synthroid | 51 | $3,394 | $67 |
| Pioglitazone | 112 | $3,323 | $30 |
| Bd Ultra-Fine Pen Needle | 24 | $2,393 | $100 |
| Omega-3 Acid Ethyl Esters | 20 | $2,066 | $103 |
| Atorvastatin | 91 | $2,026 | $22 |
| Insulin | 55 | $1,744 | $32 |
| Ulticare Pen Needle | 16 | $1,579 | $99 |
| Ibandronate | 15 | $1,445 | $96 |
| Pen Needles | 39 | $1,401 | $36 |
| Insulin | 51 | $1,360 | $27 |
| Hydrocortisone | 38 | $1,206 | $32 |
| Glimepiride | 72 | $1,122 | $16 |
| Metformin Hcl Er | 121 | $1,063 | $9 |
| Methimazole | 92 | $1,056 | $11 |
| Unifine Pentips | 43 | $977 | $23 |
| Acarbose | 27 | $974 | $36 |
| Insulin | 22 | $793 | $36 |
| Glipizide Xl | 52 | $746 | $14 |
| Alendronate | 100 | $733 | $7 |
| Simvastatin | 37 | $724 | $20 |
| Calcitonin-Salmon | 13 | $684 | $53 |
| Glyburide | 27 | $585 | $22 |
| Glipizide Er | 44 | $575 | $13 |
| Pravastatin | 24 | $562 | $23 |
| Enalapril Maleate | 11 | $561 | $51 |
| Gabapentin | 72 | $561 | $8 |
| Prednisone | 32 | $476 | $15 |
| Levoxyl | 12 | $473 | $39 |
| Sure Comfort | 20 | $471 | $24 |
| Duloxetine | 13 | $379 | $29 |
| Fludrocortisone Acetate | 18 | $343 | $19 |
| Sure Comfort | 11 | $318 | $29 |
| Losartan | 33 | $294 | $9 |
| Glyburide-Metformin | 13 | $285 | $22 |
| Gemfibrozil | 12 | $281 | $23 |
| Amlodipine Besylate | 34 | $273 | $8 |
| Nifedipine Er | 12 | $268 | $22 |
| Lisinopril | 31 | $265 | $9 |
| Ondansetron | 11 | $263 | $24 |
| Valsartan | 16 | $248 | $15 |
| Trazodone | 32 | $158 | $5 |
| Atenolol | 16 | $42 | $3 |
2016: 82 drugs
| Januvia | 201 | $149,861 | $746 |
| Novolog Mix 70-30 Flexpen | 128 | $118,028 | $922 |
| Humalog Mix 75-25 Kwikpen | 168 | $116,029 | $691 |
| Humulin R U-500 | 72 | $110,345 | $1,533 |
| Forteo | 42 | $108,392 | $2,581 |
| Tradjenta | 150 | $87,001 | $580 |
| Humalog Kwikpen U-100 | 113 | $79,257 | $701 |
| Lantus Solostar | 182 | $74,206 | $408 |
| Victoza 3-Pak | 66 | $52,581 | $797 |
| Victoza 2-Pak | 91 | $45,541 | $500 |
| Humalog | 79 | $45,141 | $571 |
| Toujeo Solostar | 74 | $42,512 | $574 |
| Lantus | 91 | $42,302 | $465 |
| Novolog | 61 | $41,674 | $683 |
| Invokana | 68 | $41,218 | $606 |
| Tresiba Flextouch U-200 | 50 | $38,901 | $778 |
| Novolog Flexpen | 57 | $35,275 | $619 |
| Humalog Kwikpen U-200 | 30 | $32,000 | $1,067 |
| Bd Ultra-Fine Pen Needle | 373 | $22,670 | $61 |
| Levemir Flextouch | 57 | $20,032 | $351 |
| Humalog Mix 50-50 | 12 | $19,121 | $1,593 |
| Trulicity | 22 | $17,516 | $796 |
| Bydureon | 22 | $15,769 | $717 |
| Sensipar | 21 | $15,150 | $721 |
| Humulin R U-500 Kwikpen | 13 | $13,734 | $1,056 |
| Janumet | 27 | $13,703 | $508 |
| Levothyroxine | 451 | $12,085 | $27 |
| Humulin 70-30 | 23 | $11,483 | $499 |
| Metformin Hcl Er | 83 | $8,879 | $107 |
| Glucagon Emergency Kit | 21 | $8,285 | $395 |
| Creon | 13 | $7,924 | $610 |
| Jardiance | 16 | $7,671 | $479 |
| Repaglinide | 89 | $7,148 | $80 |
| Humulin N | 26 | $7,065 | $272 |
| Levemir | 12 | $5,866 | $489 |
| Novolin N | 31 | $4,812 | $155 |
| Metformin | 615 | $4,422 | $7 |
| Omega-3 Acid Ethyl Esters | 27 | $4,197 | $155 |
| Testosterone | 12 | $4,103 | $342 |
| Glipizide | 450 | $3,985 | $9 |
| Insulin | 88 | $2,653 | $30 |
| Insulin | 60 | $2,123 | $35 |
| Hydrocortisone | 63 | $2,108 | $33 |
| Pioglitazone | 90 | $1,818 | $20 |
| Synthroid | 30 | $1,723 | $57 |
| Nateglinide | 18 | $1,718 | $95 |
| Methimazole | 128 | $1,477 | $12 |
| Ibandronate | 16 | $1,373 | $86 |
| Unifine Pentips | 54 | $1,347 | $25 |
| Insulin | 41 | $1,279 | $31 |
| Atorvastatin | 66 | $1,266 | $19 |
| Glimepiride | 52 | $988 | $19 |
| Pen Needles | 33 | $829 | $25 |
| Alendronate | 107 | $827 | $8 |
| Novofine Autocover | 12 | $780 | $65 |
| Ulticare Pen Needle | 11 | $770 | $70 |
| Prednisone | 42 | $703 | $17 |
| Sure Comfort | 22 | $702 | $32 |
| Acarbose | 15 | $690 | $46 |
| Pravastatin | 24 | $674 | $28 |
| Glyburide | 25 | $639 | $26 |
| Gabapentin | 70 | $637 | $9 |
| Sure Comfort | 15 | $625 | $42 |
| Insulin | 19 | $563 | $30 |
| Glipizide Er | 36 | $556 | $15 |
| Fludrocortisone Acetate | 17 | $494 | $29 |
| Simvastatin | 56 | $425 | $8 |
| Losartan | 36 | $362 | $10 |
| Tamsulosin | 13 | $340 | $26 |
| Glipizide Xl | 24 | $331 | $14 |
| Amlodipine Besylate | 36 | $312 | $9 |
| Lisinopril | 34 | $306 | $9 |
| Sure Comfort | 11 | $303 | $28 |
| Nifedipine Er | 13 | $290 | $22 |
| Amitriptyline | 11 | $268 | $24 |
| Hydrochlorothiazide | 26 | $229 | $9 |
| Levoxyl | 11 | $221 | $20 |
| Gemfibrozil | 12 | $164 | $14 |
| Finasteride | 11 | $108 | $10 |
| Omeprazole | 13 | $99 | $8 |
| Trazodone | 20 | $96 | $5 |
| Alcohol Swabs | 16 | $57 | $4 |
2015: 73 drugs
| Januvia | 233 | $133,272 | $572 |
| Humulin R U-500 | 101 | $129,296 | $1,280 |
| Novolog Mix 70-30 Flexpen | 136 | $97,194 | $715 |
| Lantus Solostar | 203 | $90,734 | $447 |
| Tradjenta | 127 | $64,314 | $506 |
| Humalog Mix 75-25 Kwikpen | 76 | $51,123 | $673 |
| Humalog Kwikpen U-100 | 85 | $48,996 | $576 |
| Forteo | 20 | $47,459 | $2,373 |
| Lantus | 103 | $46,934 | $456 |
| Novolog Flexpen | 73 | $40,002 | $548 |
| Victoza 2-Pak | 71 | $36,844 | $519 |
| Victoza 3-Pak | 44 | $33,925 | $771 |
| Invokana | 51 | $33,461 | $656 |
| Novolog | 56 | $28,119 | $502 |
| Humalog | 59 | $25,525 | $433 |
| Bd Ultra-Fine Pen Needle | 281 | $16,862 | $60 |
| Humalog Mix 50-50 | 12 | $15,227 | $1,269 |
| Bydureon | 27 | $13,412 | $497 |
| Novolog Mix 70-30 | 29 | $12,954 | $447 |
| Levemir Flextouch | 26 | $11,729 | $451 |
| Levothyroxine | 433 | $11,090 | $26 |
| Humalog Mix 75-25 | 17 | $11,003 | $647 |
| Toujeo Solostar | 14 | $9,320 | $666 |
| Levemir | 22 | $9,289 | $422 |
| Bydureon | 18 | $8,998 | $500 |
| Repaglinide | 77 | $8,576 | $111 |
| Farxiga | 19 | $8,542 | $450 |
| Creon | 13 | $7,932 | $610 |
| Janumet | 16 | $7,746 | $484 |
| Humulin N | 22 | $6,892 | $313 |
| Byetta | 13 | $6,501 | $500 |
| Novolin N | 34 | $5,692 | $167 |
| Humulin 70-30 | 19 | $5,507 | $290 |
| Pioglitazone | 105 | $3,731 | $36 |
| Metformin | 492 | $3,537 | $7 |
| Glipizide | 412 | $3,281 | $8 |
| Dexilant | 14 | $3,011 | $215 |
| Insulin | 100 | $2,722 | $27 |
| Insulin | 70 | $2,430 | $35 |
| Synthroid | 36 | $2,216 | $62 |
| Hydrocortisone | 58 | $1,962 | $34 |
| Premarin | 12 | $1,768 | $147 |
| Methimazole | 140 | $1,399 | $10 |
| Insulin | 37 | $1,284 | $35 |
| Atorvastatin | 75 | $1,253 | $17 |
| Acarbose | 24 | $1,186 | $49 |
| Novofine 32 | 16 | $1,055 | $66 |
| Calcitriol | 22 | $969 | $44 |
| Glimepiride | 49 | $908 | $19 |
| Glyburide | 25 | $817 | $33 |
| Novofine Autocover | 13 | $777 | $60 |
| Pravastatin | 21 | $756 | $36 |
| Prednisone | 38 | $625 | $16 |
| Alendronate | 84 | $609 | $7 |
| Sure Comfort | 18 | $601 | $33 |
| Sure Comfort | 21 | $598 | $28 |
| Nystop | 19 | $554 | $29 |
| Simvastatin | 83 | $529 | $6 |
| Insulin | 18 | $501 | $28 |
| Metformin Hcl Er | 58 | $423 | $7 |
| Lisinopril | 60 | $359 | $6 |
| Pen Needles | 16 | $311 | $19 |
| Gabapentin | 31 | $305 | $10 |
| Unifine Pentips | 11 | $299 | $27 |
| Amitriptyline | 13 | $283 | $22 |
| Losartan | 26 | $248 | $10 |
| Hydrochlorothiazide | 20 | $247 | $12 |
| Glipizide Er | 23 | $244 | $11 |
| Amlodipine Besylate | 28 | $209 | $7 |
| Fludrocortisone Acetate | 15 | $176 | $12 |
| Topiramate | 12 | $174 | $15 |
| Gemfibrozil | 11 | $160 | $15 |
| Atenolol | 12 | $78 | $7 |
2014: 74 drugs
| Januvia | 213 | $97,000 | $455 |
| Humulin R | 94 | $87,486 | $931 |
| Humalog | 197 | $85,771 | $435 |
| Lantus Solostar | 213 | $83,539 | $392 |
| Novolog Mix 70-30 Flexpen | 114 | $62,527 | $548 |
| Forteo | 23 | $51,317 | $2,231 |
| Lantus | 117 | $42,532 | $364 |
| Humalog Mix 75-25 | 86 | $38,664 | $450 |
| Novolog Flexpen | 74 | $34,949 | $472 |
| Tradjenta | 77 | $31,128 | $404 |
| Novolog | 68 | $25,974 | $382 |
| Victoza 3-Pak | 27 | $18,657 | $691 |
| Victoza 2-Pak | 41 | $16,615 | $405 |
| Bd Ultra-Fine Pen Needle | 287 | $15,683 | $55 |
| Levemir | 34 | $14,633 | $430 |
| Creon | 17 | $13,739 | $808 |
| Humalog Mix 50-50 | 17 | $13,546 | $797 |
| Byetta | 21 | $11,911 | $567 |
| Sensipar | 18 | $9,329 | $518 |
| Novolog Mix 70-30 | 23 | $8,765 | $381 |
| Bydureon | 13 | $8,734 | $672 |
| Levothyroxine | 373 | $8,625 | $23 |
| Novolin 70-30 | 33 | $8,429 | $255 |
| Levemir Flexpen | 18 | $7,827 | $435 |
| Pioglitazone | 94 | $6,597 | $70 |
| Invokana | 13 | $6,534 | $503 |
| Janumet | 14 | $5,815 | $415 |
| Humulin N | 28 | $5,121 | $183 |
| Glucagon Emergency Kit | 13 | $4,445 | $342 |
| Actonel | 17 | $4,373 | $257 |
| Metformin | 413 | $4,187 | $10 |
| Glipizide | 365 | $3,784 | $10 |
| Insulin | 112 | $3,751 | $33 |
| Novolin N | 27 | $3,722 | $138 |
| Insulin | 75 | $2,563 | $34 |
| Synthroid | 52 | $2,528 | $49 |
| Dexilant | 13 | $2,390 | $184 |
| Repaglinide | 17 | $2,353 | $138 |
| Hydrocortisone | 46 | $2,031 | $44 |
| Premarin | 16 | $1,826 | $114 |
| Calcitriol | 21 | $1,293 | $62 |
| Acarbose | 25 | $1,132 | $45 |
| Methimazole | 110 | $1,100 | $10 |
| Tirosint | 12 | $996 | $83 |
| Atorvastatin | 53 | $972 | $18 |
| Alendronate | 94 | $960 | $10 |
| Novofine 32 | 14 | $897 | $64 |
| Insulin | 34 | $887 | $26 |
| Sure Comfort | 27 | $840 | $31 |
| Pravastatin | 28 | $807 | $29 |
| Gabapentin | 48 | $793 | $17 |
| Glimepiride | 45 | $793 | $18 |
| Novofine Autocover | 13 | $748 | $58 |
| Testosterone Cypionate | 18 | $563 | $31 |
| Sure Comfort | 15 | $561 | $37 |
| Losartan | 30 | $537 | $18 |
| Simvastatin | 79 | $528 | $7 |
| Pen Needles | 21 | $393 | $19 |
| Potassium Chloride | 11 | $388 | $35 |
| Insulin | 11 | $343 | $31 |
| Lisinopril | 45 | $332 | $7 |
| Prednisone | 21 | $330 | $16 |
| Glyburide | 22 | $318 | $14 |
| Hydrochlorothiazide | 26 | $283 | $11 |
| Metformin Hcl Er | 30 | $279 | $9 |
| Fludrocortisone Acetate | 14 | $190 | $14 |
| Novotwist | 12 | $190 | $16 |
| Omeprazole | 11 | $169 | $15 |
| Glipizide Er | 14 | $167 | $12 |
| Amlodipine Besylate | 27 | $129 | $5 |
| Zolpidem | 14 | $125 | $9 |
| Gemfibrozil | 12 | $116 | $10 |
| Atenolol | 24 | $114 | $5 |
| Alcohol Swabs | 14 | $55 | $4 |
2013: 77 drugs
| Januvia | 239 | $87,052 | $364 |
| Humalog | 216 | $76,453 | $354 |
| Humulin R | 65 | $65,745 | $1,011 |
| Novolog Mix 70-30 Flexpen | 129 | $57,292 | $444 |
| Lantus Solostar | 175 | $49,999 | $286 |
| Forteo | 32 | $46,153 | $1,442 |
| Novolog Flexpen | 82 | $30,082 | $367 |
| Lantus | 121 | $29,988 | $248 |
| Humalog Mix 75-25 | 62 | $19,804 | $319 |
| Novolin 70-30 | 70 | $16,830 | $240 |
| Bd Ultra-Fine Pen Needle | 332 | $15,023 | $45 |
| Byetta | 41 | $14,678 | $358 |
| Humalog Mix 50-50 | 25 | $12,365 | $495 |
| Tradjenta | 40 | $12,008 | $300 |
| Sensipar | 19 | $10,746 | $566 |
| Prandin | 15 | $9,788 | $653 |
| Pioglitazone | 73 | $8,212 | $112 |
| Novolog Mix 70-30 | 22 | $8,186 | $372 |
| Victoza 2-Pak | 24 | $8,067 | $336 |
| Novolog | 25 | $7,646 | $306 |
| Levemir Flexpen | 27 | $7,644 | $283 |
| Bydureon | 12 | $7,356 | $613 |
| Victoza 3-Pak | 13 | $6,309 | $485 |
| Levothyroxine | 380 | $6,284 | $17 |
| Humulin N | 43 | $6,238 | $145 |
| Androgel | 11 | $5,254 | $478 |
| Lidoderm | 13 | $5,142 | $396 |
| Metformin | 387 | $5,046 | $13 |
| Levemir | 13 | $4,862 | $374 |
| Glipizide | 344 | $4,427 | $13 |
| Novolin N | 24 | $2,877 | $120 |
| Glucagon Emergency Kit | 15 | $2,802 | $187 |
| Ibandronate | 16 | $2,727 | $170 |
| Nifedipine | 12 | $2,668 | $222 |
| Hydrocortisone | 56 | $2,443 | $44 |
| Tricor | 13 | $2,358 | $181 |
| Zetia | 14 | $2,269 | $162 |
| Simcor | 12 | $2,214 | $185 |
| Insulin | 78 | $2,149 | $28 |
| Cymbalta | 11 | $2,113 | $192 |
| Insulin | 71 | $1,867 | $26 |
| Synthroid | 39 | $1,790 | $46 |
| Methimazole | 110 | $1,693 | $15 |
| Gabapentin | 50 | $1,405 | $28 |
| Atorvastatin | 29 | $1,375 | $47 |
| Alendronate | 97 | $1,322 | $14 |
| Benicar | 11 | $1,205 | $110 |
| Insulin | 41 | $1,125 | $27 |
| Losartan | 64 | $1,010 | $16 |
| Estradiol Valerate | 11 | $1,007 | $92 |
| Simvastatin | 76 | $776 | $10 |
| Novofine Autocover | 12 | $668 | $56 |
| Novofine 32 | 14 | $659 | $47 |
| Pravastatin | 26 | $597 | $23 |
| Glimepiride | 44 | $544 | $12 |
| Fludrocortisone Acetate | 19 | $530 | $28 |
| Sure Comfort | 14 | $504 | $36 |
| Amlodipine Besylate | 44 | $452 | $10 |
| Metoprolol | 11 | $391 | $36 |
| Glyburide | 27 | $380 | $14 |
| Omeprazole | 29 | $366 | $13 |
| Sure Comfort | 12 | $343 | $29 |
| Ramipril | 13 | $342 | $26 |
| Monoject Insulin | 13 | $301 | $23 |
| Lisinopril | 41 | $290 | $7 |
| Atenolol | 42 | $281 | $7 |
| Clotrimazole-Betamethasone | 11 | $265 | $24 |
| Hydrochlorothiazide | 31 | $258 | $8 |
| Metformin Hcl Er | 23 | $256 | $11 |
| Glyburide-Metformin | 12 | $226 | $19 |
| Prednisone | 18 | $191 | $11 |
| Metoprolol | 11 | $164 | $15 |
| Zolpidem | 19 | $126 | $7 |
| Hydrocodone-Acetaminophen | 13 | $106 | $8 |
| Alcohol Swabs | 15 | $70 | $5 |
| Amitriptyline | 21 | $67 | $3 |
| Lisinopril-Hydrochlorothiazide | 12 | $48 | $4 |
Money from drug and device companies
$4,051 in 2025
| 2025 | 5 | 7 | $3,229 | $4,051 |
| 2024 | 1 | 1 | None | $121 |
| 2023 | 4 | 4 | $2,002 | $2,170 |
| 2022 | 2 | 2 | $4,000 | $4,116 |
| 2021 | 2 | 2 | $1,500 | $1,622 |
| 2020 | 4 | 9 | $5,117 | $5,252 |
| 2019 | 10 | 20 | None | $1,069 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sanofi-Aventis U.S. | Tzield | $3,480 | 3 payments
|
| Dexcom | Dexcom G6 Transmitter | $153 | 1 payment
|
| Medtronic | Minimed 780g | $147 | 1 payment
|
| Sequel Med Tech | Twiist | $145 | 1 payment
|
| Corcept Therapeutics | Korlym | $125 | 1 payment
|
See all 7 published payments
| Medtronic | Meals · 2025-11-18 | Minimed 780g | $147 |
| Dexcom | Meals · 2025-10-23 | Dexcom G6 Transmitter | $153 |
| Sanofi-Aventis U.S. | Meals · 2025-10-14 | None | $144 |
| Sanofi-Aventis U.S. | Consulting · 2025-10-14 | None | $3,229 |
| Sequel Med Tech | Meals · 2025-09-15 | Twiist | $145 |
| Sanofi-Aventis U.S. | Meals · 2025-07-14 | Tzield | $108 |
| Corcept Therapeutics | Meals · 2025-07-13 | Korlym | $125 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $121
| Abbott Laboratories | Freestyle Libre 3 | $121 | 1 payment
|
2023: $2,170
| Renalytix AI | Kidneyintelx Blood Collection Convenience Kit | $2,002 | 1 payment
|
| Dexcom | Dexcom G7 Gss (161) | $122 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $32 | 1 payment
|
| ViiV Healthcare | Dovato | $14 | 1 payment
|
2022: $4,116
| Eli Lilly and | None | $4,000 | 1 payment
|
| Lilly USA | Mounjaro | $116 | 1 payment
|
2021: $1,622
| Ascensia Diabetes Care US | None | $1,500 | 1 payment
|
| Novo Nordisk | Rybelsus | $122 | 1 payment
|
2020: $5,252
| Mannkind | Afrezza | $4,429 | 6 payments
|
| Bayer HealthCare Pharmaceuticals | Non-Covered | $688 | 1 payment
|
| Amgen | Repatha | $122 | 1 payment
|
| Insulet | Omnipod | $13 | 1 payment
|
2019: $1,069
| Novo Nordisk | Ozempic | $219 | 3 payments
|
| Tandem Diabetes Care | T-Slim Insulin Pump | $140 | 2 payments
|
| Insulet | Omnipod | $130 | 6 payments
|
| Mannkind | Afrezza | $127 | 2 payments
|
| Corcept Therapeutics | Korlym | $109 | 1 payment
|
| AbbVie | Synthroid | $102 | 1 payment
|
| Allergan | None | $93 | 1 payment
|
| Lilly USA | Trulicity | $82 | 2 payments
|
| Senseonics | Eversense | $51 | 1 payment
|
| Medtronic MiniMed | Minimed 670g System | $15 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Abbott Laboratories · Franklin Pilot Study · 2024 | Their institution | $73,020 |
| Abbott Laboratories · Franklin Pilot Study · 2023 | Their institution | $56,514 |
| Abbott Laboratories · Ism2211002a--Franklin Pilot Study · 2025 | Their institution | $48,090 |
| Bayer Healthcare Pharmaceuticals Inc. · Bay 948862, A Parallel-Group, Randomized, Prospective, Interventional, Double-Blind, Multicenter Global Phase 3study To Investigate the Efficacy and Safety of Finerenone Versus Placebo, in Addition To Standard of Care, in Participants With Chronic Kidney · 2024 | Their institution | $36,816 |
| Bayer Healthcare Pharmaceuticals Inc. · A Parallel-Group, Randomized, Prospective, Interventional, Double-Blind, Multicenter Global Phase 3 Study To Investigate the Efficacy and Safety of Finerenone Versus Placebo, in Addition To Standard of Care, in Participants With Chronic Kidney Disease A · 2025 | Their institution | $36,611 |
| Novo Nordisk AS · Tresiba · 2019 | Their institution | $27,924 |
| Bayer Healthcare Pharmaceuticals Inc. · Bay 948862, A Parallel-Group, Randomized, Prospective, Interventional, Double-Blind, Multicenter Global Phase 3study To Investigate the Efficacy and Safety of Finerenone Versus Placebo, in Addition To Standard of Care, in Participants With Chronic Kidney · 2025 | Their institution | $24,457 |
| Abbott Laboratories · Franklin Pilot Study · 2022 | Their institution | $522 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1023196805
- Licence
- CA A72355California A72355: Current · expires 2028-04-30
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A723550
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-11-01
- NPI last updated
- 2024-04-15
- NPI record certified
- 2024-04-15
This is when the NPI record was last certified, not a medical board exam.